US and Mexican controls on precursor chemicals may reduce cocaine and meth use in the US

After changing little during the early 2000s, cocaine use in the USA began a downward shift at the time of the sodium permanganate regulation. In association with that regulation, there was an estimated decrease of approximately 1.9 million past-year cocaine users (a drop of 32%) and 0.7 million past-month cocaine users (-29%). During the period examined following the sodium permanganate regulation (December 2006 to December 2014), there was little or no recovery in the number of cocaine users.
Methamphetamine use in the USA also began a downward shift at the time of the chemical company closure. In association with Mexico's 03/2007 chemical company closure, there was an estimated decrease of approximately half a million past-year methamphetamine users (-35%), and a decrease of a little more than a quarter million past-month methamphetamine users (-45%). During the period examined following closure of the chemical company (March 2007 to December 2014), methamphetamine user numbers generally remained below pre-closure levels, though a partial recovery in the numbers may have occurred in 2013.
Lead author James Cunningham, PhD, says, "Cocaine and methamphetamine production for international markets requires access to massive amounts of legally manufactured chemicals. Disrupting that access should disrupt the drugs' availability and use." He also says, "Strategies directed towards individual users, for example, information campaigns and direct medical care, have not yet fully addressed the public health problem of cocaine and methamphetamine abuse, indicating the need for additional approaches. To this end, and given our study's findings, control of essential and precursor chemicals warrants a closer look."



for more information visit our product website:Buy Cenforce 200 mg Online 
Location: United States

Comments

Post a Comment

Popular posts from this blog

Study supports new strategy to fight cocaine addiction

Prior experiments targeting this receptor, known as the TrkB receptor, produced results that differed greatly according to the brain region involved. The new study is the first to test system-wide delivery -- the way drugs are typically given in humans -- of a TrkB-blocker, s howing that the overall effect is to reverse cocaine dependency. "I think this study could help revive the idea of targeting TrkB signaling to treat addiction," said TSRI biologist Candice Contet, senior author of the study. Struggle to Find Solutions Scientists have long struggled to find an effective strategy against cocaine addiction, which is estimated to affect more than two million Americans, resulting annually in about half a million emergency room visits and hundreds of thousands of rehab facility admissions. There is still no FDA-approved drug specifically for treating cocaine addiction. Addiction researchers know tha t cocaine produces a huge surge in the levels of dopamine in the ...
Read more

Safer opioid painkiller made from scratch

Image
A brand new technique of creating painkillers could result in various medicines with out the unintended effects, say researchers. Credit score: © stevecuk / Fotolia A global crew of researchers -- led by scientists at UC San Francisco, Stanford College, the College of North Carolina (UNC), and the Friedrich-Alexander College Erlangen-Nürnberg in Germany -- has developed a brand new opioid drug candidate that blocks ache with out triggering the damaging unintended effects of present prescription painkillers. Their secret? Ranging from scratch -- with computational methods that allow them discover greater than 4 trillion completely different chemical interactions. In a brand new research -- printed on-line August 17, 2016 in  Nature  -- the researchers used the newly deciphered atomic construction of the mind's "morphine receptor" to custom-engineer a novel drug candidate that blocked ache as successfully as morphine in mouse experiments, however didn...
Read more